# 2025-12368: Medicare Reworks the Payment Plumbing for Kidney Dialysis

2025-12368, Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model, is a Federal Register proposed rule from Health and Human Services Department, Centers for Medicare & Medicaid Services published 2025-07-02, effective 2026-01-01; deemed significant under Executive Order 12866; PRIA reads it as touching household money (as of 2026-11-09).

- Canonical: https://policyrisk.com/federal-register/2025-12368
- As of: 2026-11-09
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-12368
- Title: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model
- Type: Proposed Rule
- Agencies: Health and Human Services Department; Centers for Medicare & Medicaid Services
- Citation: 90 FR 29342
- Published: 2025-07-02
- Effective: 2026-01-01
- Comments close: not stated
- Significant: yes (OIRA_API)
- Touches household money: yes
- Regulation identifier numbers: 0938-AV52
- Last updated: 2026-11-09

## In one line

Medicare Reworks the Payment Plumbing for Kidney Dialysis

## Summary

Starting in 2026, Medicare is updating how it pays for kidney dialysis for people with end-stage renal disease and those with acute kidney injury. The rule also tweaks quality programs and changes the ESRD Treatment Choices Model to improve care and payment fairness. Patients, dialysis centers, and healthcare providers should watch for these changes, with public comments open until August 29, 2025.

## Abstract

This proposed rule would update and revise the End-Stage Renal Disease (ESRD) Prospective Payment System for calendar year 2026. This rule also proposes to update the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury. In addition, this rule proposes to update requirements for the ESRD Quality Incentive Program and to terminate and modify requirements for the ESRD Treatment Choices Model.

## Effects PRIA read

- CY 2026 ESRD base rate rises to $281.06: mixed, high. For calendar year (CY) 2026, CMS proposes an ESRD Prospective Payment System (PPS) base rate of $281.06 per treatment, up from $273.82 in CY 2025. CMS estimates aggregate Medicare payments to ESRD facilities would increase by about $160 million in CY 2026 and beneficiary coinsurance payments would…
- AKI dialysis payment set to $281.06: benefit, low. CMS proposes the annual payment rate for renal dialysis furnished to individuals with acute kidney injury (AKI) for CY 2026 to be $281.06, the same as the proposed ESRD PPS base rate. CMS estimates aggregate Medicare payments for AKI dialysis would increase by $1 million (a 1.8% increase) in CY 202…
- Outlier payment amounts for CY 2026 decrease: cost, low. CMS proposes updates to the ESRD outlier policy and would reduce the fixed dollar loss (FDL) and Medicare allowable payment (MAP) amounts for CY 2026: pediatric FDL from $234.26 to $148.38 and pediatric MAP from $59.60 to $44.09; adult FDL from $45.41 to $12.74 and adult MAP from $31.02 to $22.07.…
- Continuation of TDAPA drug payments in 2026: mixed, high. CMS proposes post‑TDAPA add-on payment amounts for specific drugs in CY 2026: Korsuva at $0.2633 per treatment and DefenCath at $1.4780 per treatment in the quarters specified. CMS estimates combined TDAPA payments for continuing drugs in CY 2026 would be about $480 million, with roughly $100 milli…
- TDAPA eligibility timeframe shortened to 3 years: mixed, medium. CMS proposes to change the TDAPA eligibility window so that a new renal dialysis drug or biological product must have been approved by the FDA within the past 3 years at the time of TDAPA application. This eligibility timeframe would apply to TDAPA applications submitted on or after January 1, 2028.
- New payment adjustment for non‑contiguous areas (NAPA): mixed, low. CMS proposes a Non-Contiguous Areas Payment Adjustment (NAPA) for ESRD facilities located in Alaska, Hawaii, Guam, American Samoa, and the Northern Mariana Islands to account for certain non-labor costs not captured in the wage index. CMS proposes the NAPA to be budget neutral and would apply a cor…
- ESRD QIP measure removals and survey reduction: cost, high. CMS proposes to remove three reporting measures from the ESRD Quality Incentive Program (QIP) beginning with Payment Year (PY) 2027: Facility Commitment to Health Equity, Screening for Social Drivers of Health, and Screen Positive Rate for Social Drivers of Health. Beginning with PY 2028, CMS propo…
- ETC Model termination as of Dec 31, 2025: cost, low. CMS proposes to terminate the End-Stage Renal Disease Treatment Choices (ETC) Model effective December 31, 2025, and to limit application of the 42 CFR part 512, subpart C payment adjustments to claims with service dates on or after January 1, 2021 and on or before December 31, 2025. CMS estimates…

## Related documents

- [2026-22381](https://policyrisk.com/federal-register/2026-22381): Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, 2026-11-03
- [2026-22194](https://policyrisk.com/federal-register/2026-22194): Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury (AKI) Dialysis Paym…, 2026-10-30
- [2026-21420](https://policyrisk.com/federal-register/2026-21420): Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026, 2026-10-20
- [2026-20281](https://policyrisk.com/federal-register/2026-20281): Global Benchmark for Efficient Drug Pricing (GLOBE) Model, 2026-10-02
- [2026-20131](https://policyrisk.com/federal-register/2026-20131): Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality…, 2026-10-01
- [2026-19959](https://policyrisk.com/federal-register/2026-19959): Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Prog…, 2026-09-30

## Sources
- [2025-12368 on federalregister.gov](https://www.federalregister.gov/documents/2025/07/02/2025-12368/medicare-program-end-stage-renal-disease-prospective-payment-system-payment-for-renal-dialysis)
- [2025-12368 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-07-02/pdf/2025-12368.pdf)

## Related
- [Previous: 2025-12347, Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Paym…](https://policyrisk.com/federal-register/2025-12347)
- [Next: 2025-12369, Airworthiness Directives; Bombardier, Inc., Airplanes](https://policyrisk.com/federal-register/2025-12369)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-12368 (as of 2026-11-09).
